CCEL vs HCA
Loading...
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCEL is a Hold and HCA is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CCEL’s FA Score shows that 2 FA rating(s) are green whileHCA’s FA Score has 2 green FA rating(s).
- CCEL’s FA Score: 2 green, 3 red.
- HCA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HCA’s TA Score shows that 6 TA indicator(s) are bullish.
- HCA’s TA Score: 6 bullish, 4 bearish.
Price Growth
CCEL (@Medical/Nursing Services) experienced а +5.43% price change this week, while HCA (@Medical/Nursing Services) price change was -0.01% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.64%. For the same industry, the average monthly price growth was -0.65%, and the average quarterly price growth was +12.10%.
Reported Earning Dates
CCEL is expected to report earnings on Jul 12, 2024.
HCA is expected to report earnings on Jul 25, 2024.
Industries' Descriptions
@Medical/Nursing Services (+1.64% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| CCEL | HCA | CCEL / HCA | |
| Capitalization | 61.8M | 88.2B | 0% |
| EBITDA | 6.98M | 12.7B | 0% |
| Gain YTD | 52.000 | 14.547 | 357% |
| P/E Ratio | 16.37 | 17.40 | 94% |
| Revenue | 31.2M | 65B | 0% |
| Total Cash | 1.21M | 935M | 0% |
| Total Debt | 12.5M | 41.9B | 0% |
CCEL | HCA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 69 | 13 | |
SMR RATING 1..100 | 12 | 45 | |
PRICE GROWTH RATING 1..100 | 37 | 48 | |
P/E GROWTH RATING 1..100 | 27 | 44 | |
SEASONALITY SCORE 1..100 | 95 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCA's Valuation (6) in the Hospital Or Nursing Management industry is significantly better than the same rating for CCEL (90) in the null industry. This means that HCA’s stock grew significantly faster than CCEL’s over the last 12 months.
HCA's Profit vs Risk Rating (13) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CCEL (69) in the null industry. This means that HCA’s stock grew somewhat faster than CCEL’s over the last 12 months.
CCEL's SMR Rating (12) in the null industry is somewhat better than the same rating for HCA (45) in the Hospital Or Nursing Management industry. This means that CCEL’s stock grew somewhat faster than HCA’s over the last 12 months.
CCEL's Price Growth Rating (37) in the null industry is in the same range as HCA (48) in the Hospital Or Nursing Management industry. This means that CCEL’s stock grew similarly to HCA’s over the last 12 months.
CCEL's P/E Growth Rating (27) in the null industry is in the same range as HCA (44) in the Hospital Or Nursing Management industry. This means that CCEL’s stock grew similarly to HCA’s over the last 12 months.
| HCA | |
|---|---|
| RSI ODDS (%) | 2 days ago 67% |
| Stochastic ODDS (%) | 2 days ago 77% |
| Momentum ODDS (%) | 2 days ago 65% |
| MACD ODDS (%) | 2 days ago 70% |
| TrendWeek ODDS (%) | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 61% |
| Advances ODDS (%) | 3 days ago 69% |
| Declines ODDS (%) | 7 days ago 55% |
| BollingerBands ODDS (%) | 2 days ago 81% |
| Aroon ODDS (%) | 2 days ago 72% |
CCEL and
Correlation & Price change
A.I.dvisor tells us that CCEL and AGL have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CCEL and AGL's prices will move in lockstep.
| Ticker / NAME | Correlation To CCEL | 1D Price Change % | ||
|---|---|---|---|---|
| CCEL | 100% | +1.27% | ||
| AGL - CCEL | 14% Poorly correlated | +4.22% | ||
| IONM - CCEL | 14% Poorly correlated | -11.86% | ||
| LFST - CCEL | 7% Poorly correlated | N/A | ||
| HCA - CCEL | 4% Poorly correlated | -1.60% | ||
| ACHC - CCEL | 4% Poorly correlated | -2.03% | ||
More | ||||
HCA and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCA has been loosely correlated with THC. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if HCA jumps, then THC could also see price increases.